Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study

por Hussein, Ziad, Majid, Oneeb, Boyd, Peter, Aluri, Jagadeesh, Ngo, Leock Y, Reyderman, Larisa
Publicado 2022

Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent...

por Husni, Ryan Edbert, Ngo, Leock Y., Senokuchi, Hirofumi, Patten, Anna, Hiramatsu, Hidetaka, Watanabe, Kazuaki, Yamamoto, Takamichi
Publicado 2021

Time to exceed pre‐randomization monthly seizure count for perampanel in participants with primary generalized tonic–clonic seizures: A potential clinical end point

por Kerr, Wesley T., Brandt, Christian, Ngo, Leock Y., Patten, Anna, Cheng, Jocelyn Y., Kramer, Lynn, French, Jacqueline A.
Publicado 2022

Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized t...

por Fogarasi, Andras, Flamini, Robert, Milh, Mathieu, Phillips, Steven, Yoshitomi, Shinsaku, Patten, Anna, Takase, Takao, Laurenza, Antonio, Ngo, Leock Y.
Publicado 2020

Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy

por Hanaya, Ryosuke, Kubota, Yuichi, Mizobuchi, Masahiro, Iida, Koji, Ono, Tomonori, Motooka, Hiromichi, Nakano, Naoki, Fujimoto, Ayataka, Iwasaki, Masaki, Fukuda, Masafumi, Kondo, Akihiko, Uruno, Katsuhisa, Yamamuro, Shintaro, Yamaguchi, Kohei, Onishi, Kisaki, Ngo, Leock Y, Inoue, Yushi
Publicado 2023